386 related articles for article (PubMed ID: 32451498)
1. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.
Roberti MP; Yonekura S; Duong CPM; Picard M; Ferrere G; Tidjani Alou M; Rauber C; Iebba V; Lehmann CHK; Amon L; Dudziak D; Derosa L; Routy B; Flament C; Richard C; Daillère R; Fluckiger A; Van Seuningen I; Chamaillard M; Vincent A; Kourula S; Opolon P; Ly P; Pizzato E; Becharef S; Paillet J; Klein C; Marliot F; Pietrantonio F; Benoist S; Scoazec JY; Dartigues P; Hollebecque A; Malka D; Pagès F; Galon J; Gomperts Boneca I; Lepage P; Ryffel B; Raoult D; Eggermont A; Vanden Berghe T; Ghiringhelli F; Vandenabeele P; Kroemer G; Zitvogel L
Nat Med; 2020 Jun; 26(6):919-931. PubMed ID: 32451498
[TBL] [Abstract][Full Text] [Related]
2. Turning tolerogenic into immunogenic ileal cell death through ileal microbiota: the key to unlock the mystery of colon cancer immunoscore?
Roberti MP; Picard M; Yonekura S; Zitvogel L
Oncoimmunology; 2020 Jun; 9(1):1778834. PubMed ID: 32923141
[TBL] [Abstract][Full Text] [Related]
3. Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota.
Fidelle M; Yonekura S; Picard M; Cogdill A; Hollebecque A; Roberti MP; Zitvogel L
Front Immunol; 2020; 11():600886. PubMed ID: 33381121
[TBL] [Abstract][Full Text] [Related]
4. Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients.
Picard M; Yonekura S; Slowicka K; Petta I; Rauber C; Routy B; Richard C; Iebba V; Tidjani Alou M; Becharef S; Ly P; Pizzato E; Lehmann CHK; Amon L; Klein C; Opolon P; Gomperts Boneca I; Scoazec JY; Hollebecque A; Malka D; Ghiringhelli F; Dudziak D; Berx G; Vereecke L; van Loo G; Kroemer G; Zitvogel L; Roberti MP
Cell Death Differ; 2021 May; 28(5):1532-1547. PubMed ID: 33262469
[TBL] [Abstract][Full Text] [Related]
5. Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages.
Limagne E; Thibaudin M; Nuttin L; Spill A; Derangère V; Fumet JD; Amellal N; Peranzoni E; Cattan V; Ghiringhelli F
Cancer Immunol Res; 2019 Dec; 7(12):1958-1969. PubMed ID: 31611243
[TBL] [Abstract][Full Text] [Related]
6. Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Vernieri C; Galli F; Ferrari L; Marchetti P; Lonardi S; Maiello E; Iaffaioli RV; Zampino MG; Zaniboni A; De Placido S; Banzi M; Damiani A; Ferrari D; Rosati G; Labianca RF; Bidoli P; Frassineti GL; Nicolini M; Pavesi L; Tronconi MC; Buonadonna A; Ferrario S; Re GL; Adamo V; Tamburini E; Clerico M; Giordani P; Leonardi F; Barni S; Ciarlo A; Cavanna L; Gori S; Cinieri S; Faedi M; Aglietta M; Antista M; Dotti KF; Galli F; Di Bartolomeo M;
Oncologist; 2019 Mar; 24(3):385-393. PubMed ID: 30606884
[TBL] [Abstract][Full Text] [Related]
7. Intestinal, extra-intestinal and systemic sequelae of Toxoplasma gondii induced acute ileitis in mice harboring a human gut microbiota.
von Klitzing E; Ekmekciu I; Kühl AA; Bereswill S; Heimesaat MM
PLoS One; 2017; 12(4):e0176144. PubMed ID: 28414794
[TBL] [Abstract][Full Text] [Related]
8. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
9. Impact of the ileal microbiota on colon cancer.
Roberti MP; Rauber C; Kroemer G; Zitvogel L
Semin Cancer Biol; 2022 Nov; 86(Pt 2):955-966. PubMed ID: 34624451
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antitumor effect of anti-PD-L1 combined with oxaliplatin on a mouse tumor model.
Golchin S; Alimohammadi R; Rostami Nejad M; Jalali SA
J Cell Physiol; 2019 Nov; 234(11):19866-19874. PubMed ID: 30941773
[TBL] [Abstract][Full Text] [Related]
11. P2RX7 Deletion in T Cells Promotes Autoimmune Arthritis by Unleashing the Tfh Cell Response.
Felix KM; Teng F; Bates NA; Ma H; Jaimez IA; Sleiman KC; Tran NL; Wu HJ
Front Immunol; 2019; 10():411. PubMed ID: 30949163
[TBL] [Abstract][Full Text] [Related]
12. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
Liang J; Tian XF; Yang W
World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota Drive Autoimmune Arthritis by Promoting Differentiation and Migration of Peyer's Patch T Follicular Helper Cells.
Teng F; Klinger CN; Felix KM; Bradley CP; Wu E; Tran NL; Umesaki Y; Wu HJ
Immunity; 2016 Apr; 44(4):875-88. PubMed ID: 27096318
[TBL] [Abstract][Full Text] [Related]
14. Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade.
Zboralski D; Hoehlig K; Eulberg D; Frömming A; Vater A
Cancer Immunol Res; 2017 Nov; 5(11):950-956. PubMed ID: 28963140
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic death of colon cancer cells treated with oxaliplatin.
Tesniere A; Schlemmer F; Boige V; Kepp O; Martins I; Ghiringhelli F; Aymeric L; Michaud M; Apetoh L; Barault L; Mendiboure J; Pignon JP; Jooste V; van Endert P; Ducreux M; Zitvogel L; Piard F; Kroemer G
Oncogene; 2010 Jan; 29(4):482-91. PubMed ID: 19881547
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer.
Park SJ; Ye W; Xiao R; Silvin C; Padget M; Hodge JW; Van Waes C; Schmitt NC
Oral Oncol; 2019 Aug; 95():127-135. PubMed ID: 31345380
[TBL] [Abstract][Full Text] [Related]
17. Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-Producing Escherichia coli in Apc
Lucas C; Salesse L; Hoang MHT; Bonnet M; Sauvanet P; Larabi A; Godfraind C; Gagnière J; Pezet D; Rosenstiel P; Barnich N; Bonnet R; Dalmasso G; Nguyen HTT
Gastroenterology; 2020 Apr; 158(5):1373-1388. PubMed ID: 31917256
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic cell death in colon cancer prevention and therapy.
Ruan H; Leibowitz BJ; Zhang L; Yu J
Mol Carcinog; 2020 Jul; 59(7):783-793. PubMed ID: 32215970
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic chemotherapy in two mouse colon cancer models.
Taniura T; Iida Y; Kotani H; Ishitobi K; Tajima Y; Harada M
Cancer Sci; 2020 Oct; 111(10):3527-3539. PubMed ID: 32816355
[TBL] [Abstract][Full Text] [Related]
20. Low-Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial Cells.
Pu C; Li Y; Fu Y; Yan Y; Tao S; Tang S; Gai X; Ding Z; Gan Z; Liu Y; Cao S; Wang T; Ding J; Xu J; Geng M; Huang M
Adv Sci (Weinh); 2024 Mar; 11(11):e2304781. PubMed ID: 38189627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
